ClinVar Miner

Submissions for variant NM_000548.5(TSC2):c.4909AAG[1] (p.Lys1638del)

dbSNP: rs137854261
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000517321 SCV000615915 pathogenic not provided 2014-11-20 criteria provided, single submitter clinical testing Not found in the total gnomAD dataset. Found in multiple de novo cases.
Invitae RCV000201053 SCV000765953 pathogenic Tuberous sclerosis 2 2023-10-16 criteria provided, single submitter clinical testing This variant, c.4912_4914del, results in the deletion of 1 amino acid(s) of the TSC2 protein (p.Lys1638del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with tuberous sclerosis complex (PMID: 17304050, 20165957, 21520333, 22867869). In at least one individual the variant was observed to be de novo. This variant is also known as c.4909_4911delAAG. ClinVar contains an entry for this variant (Variation ID: 49893). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic.
Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University RCV000201053 SCV001423572 likely pathogenic Tuberous sclerosis 2 2020-07-10 criteria provided, single submitter clinical testing
GeneDx RCV000517321 SCV001823756 pathogenic not provided 2020-08-17 criteria provided, single submitter clinical testing Reported multiple times as a pathogenic variant is association with tuberous sclerosis complex (Au et al., 2007, Qin et al, 2010, vanEeghen et al., 2013; TSC2 LOVD); Not observed in large population cohorts (Lek et al., 2016); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32555378, 22867869, 20165957, 17304050, 31855466)
CeGaT Center for Human Genetics Tuebingen RCV000517321 SCV001961554 pathogenic not provided 2021-07-01 criteria provided, single submitter clinical testing
Tuberous sclerosis database (TSC2) RCV000043159 SCV000066507 not provided Tuberous sclerosis syndrome no assertion provided curation
Tuberous sclerosis database (TSC2) RCV000043159 SCV000066958 not provided Tuberous sclerosis syndrome no assertion provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.